- Joined
- Nov 5, 2009
- Messages
- 14,212
- Reason
- Lost a loved one
- Diagnosis
- 00/0000
- Country
- US
- State
- WA
- City
- Seattle
The aim of this trial is to test a heart failure drug (levosimendan) already on the market to confirm an earlier study suggesting respiratory impairment could be delayed.
It's an oral capsule, the trial is placebo-controlled, and you cannot be on BiPAP.
It's an oral capsule, the trial is placebo-controlled, and you cannot be on BiPAP.